# Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

> **NCT06650826** · — · RECRUITING · sponsor: **Cardioangiologisches Centrum Bethanien** · enrollment: 200 (estimated)

## Conditions studied

- Arterial or Venous Thrombosis

## Interventions

- **DIAGNOSTIC_TEST:** Determination of anti-platelet factor 4 antibodies in the blood

## Key facts

- **NCT ID:** NCT06650826
- **Lead sponsor:** Cardioangiologisches Centrum Bethanien
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-07
- **Final completion:** 2027-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06650826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06650826, "Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06650826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*